The 10 new flu-related deaths in children bring the season's total to 226, the most since 2009-10.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
The next study phase includes examining raw data and stored blood samples.
Moderna's COVID-19 vaccine was safe in adolescents 12 to 17 years old, with a similar immune response to that in young adults, according to results of an ongoing phase 2-3 trial published in the New England Journal of Medicine yesterday.
The results help support the CDC's recommendation to vaccinate pregnant women.
Also, the CDC recommends vaccination for pregnant women, as hospitals are stretched to their limits in COVID-19 hot spots.
In another development, the WHO announced the next phase of a treatment trial, which will test three repurposed drugs across 52 countries.
Inhaled budesonide, a corticosteroid often used for Crohn's disease, was tied to a shorter recovery time in COVID-19 patients who were at a higher risk of severe infection, according to a study published in The Lancet yesterday.
Researchers continue to say the vaccines' health benefits outweigh any risks.
Some Florida and Texas districts are defying state orders against mask mandates, as more groups mandate vaccination, including the military.
Stubbornly high levels persist in nations including Thailand and Vietnam as Delta variant activity keeps countries on edge, from Australia to China.
Today Morbidity and Mortality Weekly Report (MMWR) published a summary of the findings of the Advisory Committee on Immunization Practices (ACIP) on adverse events related to the three COVID-19 vaccines approved for emergency use in the United States, two-dose mRNA vaccines from Pfizer and Moderna, and a single shot adenovirus vaccine from Johnson & Johnson.
